The Board of Regents of the University of Oklahoma

Oklahoma City, Oklahoma 73104

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Oklahoma City, OK
Click here to add this to my saved trials